Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Endocrine

• Publication date

  2020-02-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12020-020-02227-2PMID 32078118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study.

  2018cited by this paper
• Predictors of surgical outcome and early criteria of remission in acromegaly

  2018cited by this paper
• Systematic review and meta-analysis.

  2017cited by this paper
• Biochemical investigations in diagnosis and follow up of acromegaly

  2017cited by this paper
• Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

  2017cited by this paper
• Octreotide LAR treatment of acromegaly in “real life”: long-term outcome at a tertiary care center

  2015cited by this paper
• Surgical interventions and medical treatments in treatment-naïve patients with acromegaly: systematic review and meta-analysis.

  2014cited by this paper
• an update on

  2014cited by this paper
• Diagnostic features and outcome of surgical therapy of acromegalic patients: Experience of the last three decades

  2014cited by this paper
• Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.

  2014cited by this paper
• Acromegaly: an endocrine society clinical practice guideline.

  2014cited by this paper
• Factors Associated with Biochemical Remission after Microscopic Transsphenoidal Surgery for Acromegaly

  2013cited by this paper
• Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.

  2013cited by this paper
• Long-term changes in serum IGF-1 levels after successful surgical treatment of growth hormone-secreting pituitary adenoma.

  2013cited by this paper
• Case-based review

  2013cited by this paper
• Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas.

  2013cited by this paper
• Surgery and Radiosurgery for Acromegaly: A Review of Indications, Operative Techniques, Outcomes, and Complications

  2012cited by this paper
• Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging

  2012cited by this paper
• Acromegaly surgery in Manchester revisited – The impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission

  2012cited by this paper
• Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays.

  2011cited by this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.

  2011cited by this paper
• Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.

  2010cited by this paper
• Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.

  2010cited by this paper
• An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient:

  2010cited by this paper
• A consensus on criteria for cure of acromegaly.

  2010influential reference
• Cerebrospinal fluid fistula after endoscopic transsphenoidal surgery: experience in a spanish center.

  2010cited by this paper
• The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly

  2010cited by this paper
• The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.

  2009cited by this paper
• Monitoring of acromegaly: what should be performed when GH and IGF‐1 levels are discrepant?

  2009cited by this paper
• The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly

  2009cited by this paper
• Guidelines for acromegaly management: an update.

  2009cited by this paper
• Monitoring disease activity using GH and IGF‐I in the follow‐up of 501 patients with acromegaly

  2009cited by this paper
• Diagnostic challenges in acromegaly: a case-based review.

  2009cited by this paper
• Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patients

  2008cited by this paper
• Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide

  2008cited by this paper
• Management of cerebrospinal fluid leak after surgical removal of pituitary adenomas.

  2008cited by this paper
• Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status

  2006cited by this paper
• [Outcome of surgical treatment for acromegaly performed by a single neurosurgeon and cumulative meta-analysis].

  2006cited by this paper
• Factors influencing mortality in acromegaly.

  2004cited by this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF ACROMEGALY

  2004cited by this paper
• Consensus Statement

  2004cited by this paper
• Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature.

  2003cited by this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.

  2003cited by this paper
• Long‐term outcome and mortality after transsphenoidal adenomectomy for acromegaly

  2003cited by this paper
• Transsphenoidal Surgery for Acromegaly: Endocrinological Follow-up of 98 Patients

  2001cited by this paper
• Criteria for cure of acromegaly: a consensus statement.

  2000cited by this paper
• Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

  1999cited by this paper
• Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.

  1998cited by this paper
• Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings.

  1993cited by this paper

• Using machine learning to predict remission after surgery for pituitary adenoma: a systematic review and meta-analysis

  2025influential citation
• Consensus on acromegaly therapeutic outcomes: an update

  2025cites this paper
• Early Postoperative Predictors of Remission After Transsphenoidal Surgery in Acromegaly: Introduction of the PARS

  2025influential citation
• Recurrence in acromegaly: two tertiary centers experience and review of the literature

  2024cites this paper
• Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly

  2023cites this paper
• A Rare Case When Acromegaly Meets Cushing Syndrome

  2023influential citation
• Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly

  2021cites this paper
• Postoperative endocrinological follow-up

  2021cites this paper
• Impact of experience on outcomes following endoscopic transsphenoidal surgery for acromegaly.

  2021cites this paper
• A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission

  2021cites this paper
• Multidisciplinary management of acromegaly: A consensus

  2020cites this paper
• Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly

  2020cites this paper
• Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study

  2020cites this paper